EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study

Noora Nieminen, Anna-Maija Tolppanen iD, Valtteri Kaasinen, Marjaana Koponen, Sirpa Hartikainen

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70553 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Noora Nieminen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Parkinson Disease, Psychotropic Drugs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.

Methods

The prevalence of any psychotropic, benzodiazepines and related drugs (BZDRs), antidepressants, antipsychotics in six‐month time windows from five years before to five years after PD diagnosis was studied in a Finnish nationwide register‐based study of 17 379 people with clinically verified PD diagnosis during 2000–2014 and compared to a matched comparison cohort without PD (n = 115 386).

Results

During the follow‐up, psychotropic use increased from 18% to 35% in persons with PD and from 14% to 20% in the comparison cohort. Psychotropic polypharmacy and use of all psychotropic subgroups were more frequent in the PD than in the non‐PD cohort throughout the follow‐up. In comparison, cohort BZDRs were the most frequently used psychotropics during the whole follow‐up. In the PD cohort, BZDRs were the most frequently used psychotropic group until three years after PD diagnosis, with the highest prevalence just before the index date (19.4%). After that, antidepressants were the most commonly used psychotropics. In the PD cohort, the psychotropic polypharmacy increased from 5% to 10% during the follow‐up. The differences were not explained by dementia.

Conclusions

The results likely reflect the onset of non‐motor symptoms already before diagnosis and increasing symptomatology with disease progression. Alternatively, they may reflect increased healthcare contact. Still, the findings are concerning as all psychotropics increase the risk of adverse effects including falls and fall‐related fractures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePsychotropic DrugsHumansFinlandMaleAgedFemalePolypharmacyCohort StudiesAged, 80 and overIndependent LivingAntidepressive AgentsMiddle AgedFollow-Up StudiesRegistriesPrevalence

Stichwörter der Autor:innen

Parkinson's diseaseantidepressantantipsychoticcohortpsychotropic use

Substanzen

Psychotropic DrugsAntidepressive Agents

Autor:innen und Institutionen

  • School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Kuopio Research Centre of Geriatric Care, University of Eastern Finland, Kuopio, Finland.
  • Clinical Neurosciences, University of Turku, Turku, Finland.
  • Neurocenter, Turku University Hospital, Finland.

ORCID-Profile: Anna-Maija Tolppanen

Zitieren

APA

Nieminen, N., Tolppanen, A. M., Kaasinen, V., Koponen, M., & Hartikainen, S. (2026). Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70553

Vancouver

Nieminen N, Tolppanen AM, Kaasinen V, Koponen M, Hartikainen S. Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70553

BibTeX
@article{Nieminen2026,
  author = {Nieminen, Noora and Tolppanen, Anna-Maija and Kaasinen, Valtteri and Koponen, Marjaana and Hartikainen, Sirpa},
  title = {Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70553}
}
Kostenlos starten →